These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27133272)

  • 1. [Hyper-free fatty acidemia - insulin resistance and β-cell death].
    Csala M
    Orv Hetil; 2016 May; 157(19):733-9. PubMed ID: 27133272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus.
    Maassen JA; Romijn JA; Heine RJ
    Diabetologia; 2007 Oct; 50(10):2036-41. PubMed ID: 17712547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycerolipid/free fatty acid cycle and islet β-cell function in health, obesity and diabetes.
    Prentki M; Madiraju SR
    Mol Cell Endocrinol; 2012 Apr; 353(1-2):88-100. PubMed ID: 22108437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free fatty acids and pathogenesis of type 2 diabetes mellitus.
    Bergman RN; Ader M
    Trends Endocrinol Metab; 2000 Nov; 11(9):351-6. PubMed ID: 11042464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free fatty acids and insulin resistance.
    Delarue J; Magnan C
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):142-8. PubMed ID: 17285001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical basis and clinical consequences of glucolipotoxicity: a primer.
    Srinivasan VA; Raghavan VA; Parthasarathy S
    Heart Fail Clin; 2012 Oct; 8(4):501-11. PubMed ID: 22999235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Free Fatty Acid Receptor 2 leads to impaired islet mass and beta cell survival.
    Villa SR; Priyadarshini M; Fuller MH; Bhardwaj T; Brodsky MR; Angueira AR; Mosser RE; Carboneau BA; Tersey SA; Mancebo H; Gilchrist A; Mirmira RG; Gannon M; Layden BT
    Sci Rep; 2016 Jun; 6():28159. PubMed ID: 27324831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty Acid-Stimulated Insulin Secretion vs. Lipotoxicity.
    Ježek P; Jabůrek M; Holendová B; Plecitá-Hlavatá L
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29921789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [THE UNESTERIFIED FATTY ACIDS IN BLOOD PLASMA AND INTERCELLULAR MEDIUM: EFFECT OF INSULIN AND ALBUMIN (THE LECTURE)].
    Titov VN; Shoibonov BB
    Klin Lab Diagn; 2016 Feb; 61(2):93-101. PubMed ID: 27455563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of palmitic acid-mediated lipotoxicity by arachidonic acid via channeling of palmitic acid into triglycerides in C2C12.
    Cheon HG; Cho YS
    J Biomed Sci; 2014 Feb; 21(1):13. PubMed ID: 24521082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty Acid Metabolic Remodeling During Type 2 Diabetes Remission After Bariatric Surgery.
    Grenier-Larouche T; Carreau AM; Geloën A; Frisch F; Biertho L; Marceau S; Lebel S; Hould FS; Richard D; Tchernof A; Carpentier AC
    Diabetes; 2017 Nov; 66(11):2743-2755. PubMed ID: 28835473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β-Cell Dysfunction.
    Keane KN; Cruzat VF; Carlessi R; de Bittencourt PI; Newsholme P
    Oxid Med Cell Longev; 2015; 2015():181643. PubMed ID: 26257839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free fatty acids and type 2 diabetes mellitus.
    Wyne KL
    Am J Med; 2003 Dec; 115 Suppl 8A():29S-36S. PubMed ID: 14678863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Good, the Bad, and the Ugly - role of the pancreas, endothelium, and adipose tissue axis in the management of pancreatic β-cell failure in obesity-related type 2 diabetes.
    Janikiewicz J; Pawelec P; Kucharczyk P; Dobrzyń A
    Postepy Biochem; 2018 Oct; 64(2):166-174. PubMed ID: 30656899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Features of fatty-acid spectrum of triglycerides in patients with insulin resistance and metabolic syndrome].
    Korpachev VV; Kushnar'ova NM
    Lik Sprava; 2009; (7-8):50-5. PubMed ID: 20455448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Metabolic Disease-Associated Inflammation by Nutrient Sensors.
    Yamashita AS; Belchior T; Lira FS; Bishop NC; Wessner B; Rosa JC; Festuccia WT
    Mediators Inflamm; 2018; 2018():8261432. PubMed ID: 30116154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From obesity to diabetes.
    Keller U
    Int J Vitam Nutr Res; 2006 Jul; 76(4):172-7. PubMed ID: 17243079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.